Table of Contents
Volume 5 | Supplement 1
Publication Date: April 2005- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Introduction | ||
S10 |
Emerging Trends in the Management of Colorectal Cancer Edward Chu |
|
Contributions | ||
S11-S18 |
An Overview of Approaches to Adjuvant Therapy for Colorectal Cancer in the United States Timothy J. Hobday |
|
S19-S27 |
Epidermal Growth Factor Receptor as a Target for Chemotherapy Daniel Vallböhmer, Heinz-Josef Lenz |
|
S28-S33 |
Cetuximab in Previously Treated Colorectal Cancer Naureen Starling, David Cunningham |
|
S34-S37 |
Irinotecan-Based Regimens in the Adjuvant Therapy of Colorectal Cancer Jean-Yves Douillard |
|
S38-S46 |
Clinical Management of Oxaliplatin-Associated Neurotoxicity Axel Grothey |
|
S47-S50 |
Benefits and Drawbacks of the Use of Oral Fluoropyrimidines as Single-Agent Therapy in Advanced Colorectal Cancer Jim Cassidy |
|